Copyright
©The Author(s) 2020.
World J Clin Oncol. Aug 24, 2020; 11(8): 673-678
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.673
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.673
Hormone | Normal range | Before chemotherapy | During/after chemotherapy | ||
After the first cycle of chemotherapy | After six cycles of chemotherapy | After 1 yr of chemotherapy | |||
Thyroid-stimulating hormone | 0.38-4.31 µIU/mL | 0.04 | 0.28 | 0.52 | 0.50 |
Free T3 | 2.17-3.34 pg/mL | 0.71 | 1.17 | 2.39 | 2.00 |
Free T4 | 0.82-1.63 ng/dL | 0.63 | 1.22 | 1.22 | 1.74 |
Growth hormone | 0.13-9.88 ng/mL | 0.68 | 0.33 | 0.35 | 0.24 |
Prolactin | 3.1-15.4 ng/mL | 24.20 | 25.60 | 16.80 | |
Adrenocorticotropic hormone | 7.2-63.3 pg/mL | 5.00 | 10.70 | 1.90 | < 1.5 |
Luteinizing hormone | 5.72-64.31 mIU/mL | < 0.1 | < 0.1 | 7.70 | 8.90 |
Follicle-stimulating hormone | 0-157.79 mIU/mL | 0.50 | 0.70 | 19.60 | 25.10 |
Cortisol 8 a.m. | 4.5-21.1 µg/dL | 3.40 | 5.60 | 38.70 | 20.10 |
- Citation: Kawahigashi T, Teshima S, Tanaka E. Intravascular lymphoma with hypopituitarism: A case report. World J Clin Oncol 2020; 11(8): 673-678
- URL: https://www.wjgnet.com/2218-4333/full/v11/i8/673.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i8.673